ZNTL · Zentalis Pharmaceuticals, Inc.
Market Cap
$285.97M
Shares
71.67M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Key facts
CIK
1725160
CUSIP
98943L107
13F (30d)
85 filings
85 filers
Visit website
Investor relations